Chinese consensus guidelines for diagnosis and management of gastrointestinal stromal tumor

被引：142

作者：

Li, Jian ^{[1
]}

Ye, Yingjiang ^{[2
]}

Wang, Jian ^{[3
]}

Zhang, Bo ^{[4
]}

Qin, Shukui ^{[5
]}

Shi, Yingqiang ^{[6
]}

He, Yulong ^{[7
]}

Liang, Xiaobo ^{[8
]}

Liu, Xiufeng ^{[5
]}

Zhou, Ye ^{[6
]}

Wu, Xin ^{[9
]}

Zhang, Xinhua ^{[7
]}

Wang, Ming ^{[10
]}

Gao, Zhidong ^{[2
]}

Lin, Tianlong ^{[10
]}

Cao, Hui ^{[10
]}

Shen, Lin ^{[1
]}

机构：

[1] Peking Univ, Canc Hosp & Inst, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100142, Peoples R China

[2] Peking Univ, Peoples Hosp, Dept Gastrointestinal Surg, Beijing 100044, Peoples R China

[3] Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R China

[4] Sichuan Univ, Huaxi Hosp, Dept Gastrointestinal Surg, Chengdu 610041, Sichuan, Peoples R China

[5] 81St Hosp Peoples Liberat Army, Peoples Liberat Army Canc Ctr, Dept Med Oncol, Nanjing 210002, Jiangsu, Peoples R China

[6] Fudan Univ, Canc Hosp, Dept Gastr Surg, Shanghai 200032, Peoples R China

[7] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Gastrointestinal Surg, Guangzhou 510080, Guangdong, Peoples R China

[8] Shanxi Prov Canc Hosp, Dept Gastrointestinal Surg, Taiyuan 030013, Shanxi, Peoples R China

[9] Chinese Peoples Liberat Army Gen Hosp, Dept Gen Surg, Beijing 100853, Peoples R China

[10] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Gen Surg, Shanghai 200127, Peoples R China

来源：

CHINESE JOURNAL OF CANCER RESEARCH | 2017年 / 29卷 / 04期

关键词：

Gastrointestinal stromal tumor; diagnosis; therapy; consensus; ADJUVANT IMATINIB MESYLATE; V600E BRAF MUTATIONS; WILD-TYPE GIST; SUCCINATE-DEHYDROGENASE; RESPONSE EVALUATION; CLINICAL-PRACTICE; RANDOMIZED-TRIAL; FOLLOW-UP; KIT; EFFICACY;

D O I：

10.21147/j.issn.1000-9604.2017.04.01

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

In order to further promote the standardization of diagnosis and treatment of gastrointestinal stromal tumor (GIST) in China, the members of Chinese Society of Clinical Oncology (CSCO) Expert Committee on GIST thoroughly discussed the key contents of the consensus guidelines, and voted on the controversial issue. In final, the Chinese consensus guidelines for the diagnosis and management of GIST (2017 edition) was formed on the basis of 2013 edition consensus guidelines, which is hereby announced. The consensus included the pathological diagnosis, recurrence risk classification evaluation, targeted agent therapy, surgery and principles of surveillance of GIST.

引用

页码：281 / 293

页数：13

共 63 条

[1] V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours [J].